{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:09:42Z","timestamp":1793383782425,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41379-021-00937-0","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T10:03:04Z","timestamp":1632823384000},"page":"306-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-8638","authenticated-orcid":false,"given":"Amy","family":"Chadburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-4067","authenticated-orcid":false,"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-4808","authenticated-orcid":false,"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00937-0_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br. J. Haematol"},{"key":"10.1038\/s41379-021-00937-0_bib2","unstructured":"Swerdlow, S. H. et al. WHO classification of Tuours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). (IARC: Lyon 2017, 2017)."},{"key":"10.1038\/s41379-021-00937-0_bib3","doi-asserted-by":"crossref","first-page":"151623","DOI":"10.1016\/j.anndiagpath.2020.151623","article-title":"American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms","volume":"49","author":"Vega","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41375-021-01191-8","article-title":"Targeted based therapy in nodal T-cell lymphomas","volume":"35","author":"Chihara","year":"2021","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib5","unstructured":"Falini, B. et al. Anaplastic large cell lymphoma, ALK-positive. In: S. H. Swerdlow et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues World Health Organization Classification of Tumours 413\u2013418 (International Agency for Research on Cancer: Lyon, 2017)."},{"key":"10.1038\/s41379-021-00937-0_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How i diagnose anaplastic large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"10.1038\/s41379-021-00937-0_bib8","doi-asserted-by":"crossref","unstructured":"Prokoph, N., Larose, H., Lim, M. S., Burke, G. A. A. & Turner, S. D. Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current Standard and beyond. Cancers 10, 99 (2018).","DOI":"10.3390\/cancers10040099"},{"key":"10.1038\/s41379-021-00937-0_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2016-05-717793","article-title":"Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target","volume":"129","author":"Werner","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/gcc.20701","article-title":"Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study","volume":"48","author":"Youssif","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-021-00937-0_bib11","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"10.1038\/s41379-021-00937-0_bib13","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib15","doi-asserted-by":"crossref","unstructured":"Lobello, C. et al. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemiahttps:\/\/doi.org\/10.1038\/s41375-020-01093-1 (2020).","DOI":"10.1038\/s41375-020-01093-1"},{"key":"10.1038\/s41379-021-00937-0_bib16","doi-asserted-by":"crossref","unstructured":"Larose, H. et al. Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target. Haematologicahttps:\/\/doi.org\/10.3324\/haematol.2019.238766 (2020).","DOI":"10.3324\/haematol.2019.238766"},{"key":"10.1038\/s41379-021-00937-0_bib17","unstructured":"Feldman, A. L. et al. Anaplastic large cell lymphoma, ALK-negative. In: S. H. Swerdlow et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues World Health Organization Classification of Tumours 418-421 (International Agency for Research on Cancer: Lyon, 2017)."},{"key":"10.1038\/s41379-021-00937-0_bib18","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively-parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib22","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1038\/s41379-021-00937-0_bib23","first-page":"359A","article-title":"Rearrangements at the 6p25.3 locus identify a subset of systemic ALK-negative anaplastic large cell lymphomas with favorable prognosis","volume":"92","author":"Parrilla Castellar","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1038\/s41379-021-00937-0_bib24","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\u201cDouble-hit\u201d of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib26","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-021-00937-0_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","article-title":"Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts","volume":"127","author":"Scarfo","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib29","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib30","unstructured":"Willemze, R. et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues World Health Organization Classification of Tumours 392\u2013396 (International Agency for Research on Cancer: Lyon, 2017)."},{"key":"10.1038\/s41379-021-00937-0_bib31","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood.2019000785","article-title":"How I treat primary cutaneous CD30(+) lymphoproliferative disorders","volume":"134","author":"Shinohara","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000001449","article-title":"Clinical, histologic, and molecular characteristics of anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Melchers","year":"2020","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1038\/s41379-021-00937-0_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jid.2009.270","article-title":"Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators","volume":"130","author":"van Kester","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1038\/s41379-021-00937-0_bib35","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":"Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes","volume":"130","author":"Laharanne","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1038\/s41379-021-00937-0_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1038\/s41379-021-00937-0_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1038\/s41379-021-00937-0_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet. Surg. J."},{"key":"10.1038\/s41379-021-00937-0_bib40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib41","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood.2020005372","article-title":"Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma","volume":"136","author":"Los-de Vries","year":"2020","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00937-0_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41379-018-0130-7","article-title":"Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas","volume":"32","author":"Di Napoli","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00937-0_bib44","doi-asserted-by":"crossref","unstructured":"Oishi, N. et al. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma. Haematologicahttps:\/\/doi.org\/10.3324\/haematol.2019.245860 (2020).","DOI":"10.3324\/haematol.2019.245860"},{"key":"10.1038\/s41379-021-00937-0_bib45","doi-asserted-by":"crossref","first-page":"36126","DOI":"10.18632\/oncotarget.26308","article-title":"Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Blombery","year":"2018","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-021-00937-0_bib46","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib47","first-page":"5647940","article-title":"Increasing evidence for the association of breast implant-associated anaplastic large cell lymphoma and Li Fraumeni syndrome","volume":"2019","author":"Adlard","year":"2019","journal-title":"Case Rep. Genet"},{"key":"10.1038\/s41379-021-00937-0_bib48","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.2019004498","article-title":"Increased prevalence of BRCA1\/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast","volume":"136","author":"de Boer","year":"2020","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib49","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.6004\/jnccn.2020.0053","article-title":"NCCN guidelines insights: T-cell lymphomas, Version 1.2021","volume":"18","author":"Horwitz","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw"},{"key":"10.1038\/s41379-021-00937-0_bib50","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib51","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib52","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","article-title":"Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified","volume":"33","author":"Laginestra","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib54","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib55","doi-asserted-by":"crossref","unstructured":"Maura, F. et al. CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). Haematologica Online ahead of print (2020).","DOI":"10.3324\/haematol.2020.262659"},{"key":"10.1038\/s41379-021-00937-0_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2014.261","article-title":"Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis","volume":"29","author":"Schatz","year":"2015","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib57","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00937-0_bib58","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib59","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 rearrangements are a recurrent alteration in CD30+ systemic T-cell lymphomas with anaplastic morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24037-4","article-title":"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified","volume":"12","author":"Debackere","year":"2021","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00937-0_bib62","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","article-title":"Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas","volume":"114","author":"Abate","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1038\/s41379-021-00937-0_bib63","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00937-0_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients","volume":"86","author":"Lachenal","year":"2007","journal-title":"Med (Baltim)"},{"key":"10.1038\/s41379-021-00937-0_bib65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib66","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/PAS.0000000000000651","article-title":"Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections","volume":"40","author":"Nagao","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib67","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-021-00937-0_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1038\/s41379-021-00937-0_bib70","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv."},{"key":"10.1038\/s41379-021-00937-0_bib71","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib72","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib73","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.2019002401","article-title":"Van Roosbroeck, K., Marcelis, L. et al. FER and FES tyrosine kinase fusions in follicular T-cell lymphoma","volume":"135","author":"Debackere","year":"2020","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jmoldx.2018.05.012","article-title":"Multiple ways to detect IDH2 mutations in angioimmunoblastic T-cell lymphoma from immunohistochemistry to next-generation sequencing","volume":"20","author":"Dupuy","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1038\/s41379-021-00937-0_bib76","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","article-title":"T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma","volume":"4","author":"Ghione","year":"2020","journal-title":"Blood Adv."},{"key":"10.1038\/s41379-021-00937-0_bib77","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Attygalle","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib78","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib79","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America","volume":"33","author":"Montes-Mojarro","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib81","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1470-2045(19)30799-5","article-title":"Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations","volume":"21","author":"Lin","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-021-00937-0_bib82","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(16)30148-6","article-title":"Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study","volume":"17","author":"Li","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-021-00937-0_bib83","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00937-0_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492835","article-title":"Frequent mutations in natural Killer\/T cell lymphoma","volume":"49","author":"Zhang","year":"2018","journal-title":"Cell Physiol. Biochem"},{"key":"10.1038\/s41379-021-00937-0_bib85","doi-asserted-by":"crossref","unstructured":"de Mel, S. et al. The genomics and molecular biology of natural killer\/T-cell lymphoma: opportunities for translation. Int. J. Mol. Sci. 19 (2018).","DOI":"10.3390\/ijms19071931"},{"key":"10.1038\/s41379-021-00937-0_bib86","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1038\/s41379-021-00937-0_bib87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/s41379-021-00937-0_bib89","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-021-00937-0_bib91","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199805143382003","article-title":"Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients","volume":"338","author":"Liebowitz","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41379-021-00937-0_bib92","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/10428199909169621","article-title":"Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene","volume":"35","author":"Suzumiya","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1038\/s41379-021-00937-0_bib93","first-page":"1575","article-title":"Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1","volume":"8","author":"Hu","year":"1993","journal-title":"Oncogene"},{"key":"10.1038\/s41379-021-00937-0_bib94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcancer.2014.01.003","article-title":"Epigenetic regulation of EBV persistence and oncogenesis","volume":"26","author":"Tempera","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1038\/s41379-021-00937-0_bib95","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-018-0324-5","article-title":"Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma","volume":"33","author":"Peng","year":"2019","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib96","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41379-019-0392-8","article-title":"Immune subtyping of extranodal NK\/T-cell lymphoma: a new biomarker and an immune shift during disease progression","volume":"33","author":"Cho","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humpath.2018.01.005","article-title":"Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors","volume":"74","author":"Yabe","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib98","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1038\/s41379-021-00937-0_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Disco"},{"key":"10.1038\/s41379-021-00937-0_bib101","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib102","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib103","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J. Mol. Diagn."},{"key":"10.1038\/s41379-021-00937-0_bib105","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.3324\/haematol.2018.196196","article-title":"DNA methylation profiling of hepatosplenic T-cell lymphoma","volume":"104","author":"Bergmann","year":"2019","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00937-0_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat. Commun"},{"key":"10.1038\/s41379-021-00937-0_bib107","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2017-11-764357","article-title":"Novel insights into the pathogenesis of T-cell lymphomas","volume":"131","author":"Van Arnam","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib108","first-page":"493","article-title":"Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma","volume":"151","author":"Ashton-Key","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib109","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib110","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00428-005-1214-6","article-title":"Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma","volume":"446","author":"Cejkova","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1038\/s41379-021-00937-0_bib111","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.humpath.2009.11.020","article-title":"Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomic hybridization study","volume":"41","author":"Ko","year":"2010","journal-title":"Hum. Pathol"},{"key":"10.1038\/s41379-021-00937-0_bib112","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-021-00937-0_bib113","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.1506","article-title":"Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma","volume":"202","author":"Obermann","year":"2004","journal-title":"J. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib114","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41379-021-00937-0_bib116","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib117","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2010.295","article-title":"Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma","volume":"25","author":"Tan","year":"2011","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib118","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"key":"10.1038\/s41379-021-00937-0_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat. Commun"},{"key":"10.1038\/s41379-021-00937-0_bib120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ng.2894","article-title":"Identification of functional cooperative mutations of SETD2 in human acute leukemia","volume":"46","author":"Zhu","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00937-0_bib121","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib122","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"105","author":"Soderquist","year":"2020","journal-title":"Haematologica"},{"key":"10.1038\/s41379-021-00937-0_bib123","doi-asserted-by":"crossref","first-page":"e68343","DOI":"10.1371\/journal.pone.0068343","article-title":"Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features","volume":"8","author":"Margolskee","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/s41379-021-00937-0_bib124","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1038\/s41379-021-00937-0_bib125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1038\/s41379-021-00937-0_bib126","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1038\/s41379-021-00937-0_bib127","doi-asserted-by":"crossref","unstructured":"Marcais, A. et al. Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia\/lymphoma and defines an unfavorable indolent subtype. Leukemiahttps:\/\/doi.org\/10.1038\/s41375-020-0900-3 (2020).","DOI":"10.1038\/s41375-020-0900-3"},{"key":"10.1038\/s41379-021-00937-0_bib128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2005.09.014","article-title":"Phosphorylation of the CARMA1 linker controls NF-kappaB activation","volume":"23","author":"Sommer","year":"2005","journal-title":"Immunity"},{"key":"10.1038\/s41379-021-00937-0_bib129","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2006-11-058388","article-title":"Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein","volume":"110","author":"Cheng","year":"2007","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib130","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell Leuk\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1038\/s41379-021-00937-0_bib131","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","article-title":"Molecular hallmarks of adult T cell leukemia","volume":"3","author":"Yamagishi","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1038\/s41379-021-00937-0_bib132","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1038\/s41379-021-00937-0_bib133","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1349-7006.2001.tb02151.x","article-title":"Possible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemia","volume":"92","author":"Imaizumi","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1038\/s41379-021-00937-0_bib134","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib135","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41379-018-0037-3","article-title":"Adult T-cell leukemia\/lymphoma can be indistinguishable from other more common T-cell lymphomas. The University of Miami experience with a large cohort of cases","volume":"31","author":"Khanlari","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1038\/s41379-021-00937-0_bib136","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2018-02-835991","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood"},{"key":"10.1038\/s41379-021-00937-0_bib137","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cjp2.180","article-title":"Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia\/lymphoma","volume":"7","author":"Fujii","year":"2021","journal-title":"J. Pathol. Clin. Res."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00937-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00937-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222003076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00937-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:31:00Z","timestamp":1760229060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222003076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0893395222003076"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00937-0","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00937-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}